Quartesian Expands Global Footprint for "Clinical Data Your Way"
pharmatechoutlook

Quartesian Expands Global Footprint for "Clinical Data Your Way"

By Pharma Tech Outlook | Friday, November 30, 2018

PRINCETON, N.J.: Quartesian, a leading data clinical research organization (CRO) known for delivering "Clinical Data Your Way" from early and late stage clinical studies for virtual, biotechnology, and small to mid-sized pharma as well as from generic clinical endpoint studies today announced the opening of new and expanded offices in Bangalore and Chennai, India and Kiev, Ukraine to better serve its growing client base. Quartesian also has plans to open a third office in Hyderabad, India in the second quarter of 2017.  These state-of-the-art facilities will offer an array of clinical trial services including Electronic Data Capture, Data Management, CDISC, Biostatistical and SAS programming services.  Quartesian's clients include multinational pharmaceutical companies, CROs, generic manufacturers and biotechnology companies around the globe.

"Our new offices will serve as important hubs that enable cost effective, high quality delivery of tailored resources and services to our global clients," said Soumitra Chowdhury, COO, Quartesian. "Infrastructure investments and the recruitment of local expert talent highlights Quartesian's continued commitment to providing Clinical Data Your Way for its growing customer base."

Together, the Bangalore, Chennai, and Kiev offices are currently a combined space of over 24,000 square feet to support clinical data services across key therapeutic areas. These global hubs showcase the depth of coverage Quartesian provides to its customers as well as perfectly position the company for future growth. "Our expansion will provide the resources needed for regional data experts to assemble and deliver high quality, cost effective data services to our global customer base," said Benjamin Jackson, CEO.

Quartesian's expansion in the India and Ukraine was prompted by the tremendous recent year-over-year growth and increased interest in the unique combination of clinical trial data services delivered quickly and cost effectively to its customers.   The ability to rapidly add additional experienced resources makes Quartesian an ideal choice for CROs looking to supplement their short and long term staffing needs as well as pharma, biotech and generic companies looking for data services support for not only their localized, but also their global projects.

Weekly Brief

New Editions